From October 1, 2023 to December 31, 2023, the company has repurchased 3,738,100 shares, representing 0.78% for ¥10,060.35 million. With this, the company has completed the repurchase of 13,627,300 shares, representing 2.81% for ¥37,244.18 million under the buyback announced on July 25, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,274 JPY | -0.87% | -2.17% | -9.64% |
30/04 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
29/04 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.64% | 6.92B | |
+18.67% | 43.74B | |
+21.99% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B | |
+9.14% | 4.83B |
- Stock Market
- Equities
- 4528 Stock
- News Ono Pharmaceutical Co., Ltd.
- Tranche Update on Ono Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.